The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 39,905 | 2,314,648 | SH | SOLE | 2,314,648 | 0 | 0 | ||
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,468 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 38,787 | 5,637,630 | SH | SOLE | 5,637,630 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 11,671 | 481,094 | SH | SOLE | 481,094 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 26,221 | 3,500,768 | SH | SOLE | 3,500,768 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 8,606 | 920,464 | SH | SOLE | 920,464 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 8,215 | 241,199 | SH | SOLE | 241,199 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 17,847 | 5,738,500 | SH | SOLE | 5,738,500 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 31,460 | 854,652 | SH | SOLE | 854,652 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 2,941 | 305,125 | SH | SOLE | 305,125 | 0 | 0 | ||
| GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 3,850 | 3,079,756 | SH | SOLE | 3,079,756 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 37,278 | 2,214,961 | SH | SOLE | 2,214,961 | 0 | 0 | ||
| IMMUNIC INC | COM | 4525EP101 | 10,091 | 893,013 | SH | SOLE | 893,013 | 0 | 0 | ||
| INVENTIVA SA | ADS | 46124U107 | 2,994 | 262,658 | SH | SOLE | 262,658 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,607 | 312,553 | SH | SOLE | 312,553 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 26,245 | 3,561,052 | SH | SOLE | 3,561,052 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 12,486 | 776,514 | SH | SOLE | 776,514 | 0 | 0 | ||
| MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 2,190 | 1,954,970 | SH | SOLE | 1,954,970 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 48,026 | 1,816,421 | SH | SOLE | 1,816,421 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,603 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 7,859 | 331,886 | SH | SOLE | 331,886 | 0 | 0 | ||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 14,103 | 3,711,286 | SH | SOLE | 3,711,286 | 0 | 0 | ||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 6,054 | 513,930 | SH | SOLE | 513,930 | 0 | 0 | ||
| TRICIDA INC | COM | 89610F101 | 14,340 | 1,744,570 | SH | SOLE | 1,744,570 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 17,590 | 951,339 | SH | SOLE | 951,339 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 12,521 | 10,097,229 | SH | SOLE | 10,097,229 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 36,764 | 1,202,613 | SH | SOLE | 1,202,613 | 0 | 0 | ||